Importation of Prescription Drugs Final Rule Questions and Answers

May 25, 2022

Small Entity Compliance Guide on Final Rule on Importation of Prescription Drugs from Canada

Guidance for Industry

Today, FDA issued a Small Entity Compliance Guide to help small businesses comply with the final rule on importation of prescription drugs from Canada. On October 1, 2020, the Secretary of Health and Human Services issued the final rule to implement section 804(b) through (h) of the Federal Food, Drug, and Cosmetic Act to allow importation of certain prescription drugs from Canada. The final rule became effective November 30, 2020. The guidance issued today does not include any new policy. It clarifies in plain language the legal requirements in the final rule.

Download Small Entity Compliance Guide

Interested in learning more? Contact us today to find out how we can help not only with your EMA/FDA submissions, but all of your global regulatory needs.

Agency Alerts General Regulatory

September 2, 2015

Kim Kardashian Cleans Up Social Media Mess for Duchesnay

As we noted a few weeks ago, Duchesnay, the company that manufactures prescription morning sickness medication Diclegis, received a warning letter from FDA after Kim Kardashian posted a "selfie" on...

Read the Full Article
Agency Alerts Ophthalmic

March 22, 2022

FDA Issues Guidance on Certain Ophthalmic Products: Policy for Compliance with 21 CFR Part 4

The U.S. Food and Drug Administration today issued the guidance for industry, Certain Ophthalmic Products: Policy Regarding Compliance With 21 CFR Part 4. This guidance provides information to...

Read the Full Article
Agency Alerts Regulatory Sciences

August 14, 2018

FDA Medical Device User Fee Rates: Fiscal Year 2019

On Monday, July 30th, FDA released the medical device user fee rates for fiscal year 2019. The total FY 2019 revenue amount, prior to adjustments, is $190,654,875. Medical device user fee rates are...

Read the Full Article